CoChat

Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?

Open access
Caroppo, Paola, the Predict-PGRN study group, Habert, Marie-Odile, Durrleman, Stanley, Funkiewiez, Aurélie, Perlbarg, Vincent, Hahn, Valérie, Bertin, Hugo, Gaubert, Malo, Routier, Alexandre, Hannequin, Didier, Deramecourt, Vincent, Pasquier, Florence, Rivaud-Pechoux, Sophie, Vercelletto, Martine, Edouart, Geoffrey, Valabregue, Romain, Lejeune, Pascal, Didic, Mira, Corvol, Jean-Christophe, Benali, Habib, Lehericy, Stephane, Dubois, Bruno, Colliot, Olivier, Brice, Alexis, Le Ber, Isabelle · 2015 · Journal of Alzheimer's Disease
Cited by 39

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The preclinical stage of frontotemporal lobar degeneration (FTLD) is not well characterized. We conducted a brain metabolism (FDG-PET) and structural (cortical thickness) study to detect early changes in asymptomatic GRN mutation carriers (aGRN+) that were evaluated longitudinally over a 20-month period. At baseline, a left lateral temporal lobe hypometabolism was present in aGRN+ without any structural changes. Importantly, this is the first longitudinal study and, across time, the metabolism more rapidly decreased in aGRN+ in lateral temporal and frontal regions. The main structural change observed in the longitudinal study was a reduction of cortical thickness in the left lateral temporal lobe in carriers. A limit of this study is the relatively small sample (n = 16); nevertheless, it provides important results. First, it evidences that the pathological processes develop a long time before clinical onset, and that early neuroimaging changes might be detected approximately 20 years before the clinical onset of disease. Second, it suggests that metabolic changes are detectable before structural modifications and cognitive deficits. Third, both the baseline and longitudinal studies provide converging results implicating lateral temporal lobe as early involved in GRN disease. Finally, our study demonstrates that structural and metabolic changes could represent possible biomarkers to monitor the progression of disease in the presymptomatic stage toward clinical onset.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-150270

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 39

Metadata

Authors
Caroppo, P., the Predict-PGRN study group, Habert, M.-O., Durrleman, S., Funkiewiez, A., Perlbarg, V., Hahn, V., Bertin, H., Gaubert, M., Routier, A., Hannequin, D., Deramecourt, V., Pasquier, F., Rivaud-Pechoux, S., Vercelletto, M., Edouart, G., Valabregue, R., Lejeune, P., Didic, M., Corvol, J.-C., Benali, H., Lehericy, S., Dubois, B., Colliot, O., Brice, A., & Le Ber, I.
Venue
Journal of Alzheimer's Disease
Published
2015-08-03
Volume
47
Issue
3
Pages
751-759
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2262171011
Cited by
39
References
8
FWCI
1.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? https://app.cochat.ai/papers/10.3233/jad-150270
The paper
Caroppo, P., the Predict-PGRN study group, Habert, M.-O., Durrleman, S., Funkiewiez, A., Perlbarg, V., Hahn, V., Bertin, H., Gaubert, M., Routier, A., Hannequin, D., Deramecourt, V., Pasquier, F., Rivaud-Pechoux, S., Vercelletto, M., Edouart, G., Valabregue, R., Lejeune, P., Didic, M., . . . Le Ber, I. (2015). Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-150270

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.